2,026
Views
0
CrossRef citations to date
0
Altmetric
Research article

Role of platelet count in a murine stasis model of deep vein thrombosis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2290916 | Received 08 Aug 2023, Accepted 29 Nov 2023, Published online: 15 Dec 2023

Figures & data

Figure 1. Timeline for treatments, blood draws, surgery, and euthanasia. Antisense oligonucleotide treatment against thrombopoietin (THPO-ASO, blue triangle) and saline (red circle) were administered once a week to decrease or control for platelet count, respectively. A mimetic to thrombopoietin (TPO-mimetic, green triangle) was administered using oral gavage to mice 5 days a week and continued from surgery to euthanasia to maintain an elevated platelet count. Blood draws were analyzed weekly through complete blood count with differential. Separate cohorts of mice underwent euthanasia at post-operative day (POD) 3 and 7 to evaluate the effects of treatments on deep vein thrombus burden. Created with Biorender.com.

Figure 1. Timeline for treatments, blood draws, surgery, and euthanasia. Antisense oligonucleotide treatment against thrombopoietin (THPO-ASO, blue triangle) and saline (red circle) were administered once a week to decrease or control for platelet count, respectively. A mimetic to thrombopoietin (TPO-mimetic, green triangle) was administered using oral gavage to mice 5 days a week and continued from surgery to euthanasia to maintain an elevated platelet count. Blood draws were analyzed weekly through complete blood count with differential. Separate cohorts of mice underwent euthanasia at post-operative day (POD) 3 and 7 to evaluate the effects of treatments on deep vein thrombus burden. Created with Biorender.com.

Figure 2. Platelet count. Percent change in platelet count from baseline to surgery as a result of THPO-ASO, saline, and TPO-mimetic treatment. (N = 12 per treatment group, *** indicates p < .001, and **** indicates p < .0001, ANOVA with Tukey post-hoc).

Figure 2. Platelet count. Percent change in platelet count from baseline to surgery as a result of THPO-ASO, saline, and TPO-mimetic treatment. (N = 12 per treatment group, *** indicates p < .001, and **** indicates p < .0001, ANOVA with Tukey post-hoc).

Figure 3. DVT outcomes. Thrombus weights were measured to determine thrombus burden at post-operative day (POD) 3 and 7 (*indicated p < .05, ** p < .01, ANOVA with Tukey post-hoc).

Figure 3. DVT outcomes. Thrombus weights were measured to determine thrombus burden at post-operative day (POD) 3 and 7 (*indicated p < .05, ** p < .01, ANOVA with Tukey post-hoc).

Figure 4. Immunohistochemistry of thrombi. A–C. Trichrome staining for collagen and thrombus organization. D–F. CD31 staining for endothelial cells and channel formation indicative of neovascularization. G–I. Smooth muscle actin (SMA) staining for smooth muscle cells (** p < .01, Kruskal–Wallis with Dunn’s post-hoc). A star indicates the location of the thrombus, a diamond indicates the location of the vein wall, and an arrow identifies areas of positive staining.

Figure 4. Immunohistochemistry of thrombi. A–C. Trichrome staining for collagen and thrombus organization. D–F. CD31 staining for endothelial cells and channel formation indicative of neovascularization. G–I. Smooth muscle actin (SMA) staining for smooth muscle cells (** p < .01, Kruskal–Wallis with Dunn’s post-hoc). A star indicates the location of the thrombus, a diamond indicates the location of the vein wall, and an arrow identifies areas of positive staining.

Figure 5. Immunohistochemistry of thrombi. A–C. IBA1 staining for macrophages D–F. LY6G staining for neutrophils. G–I. H&E staining for erythrocyte, platelet, and plasma protein/fibrin content. A star indicates the location of the thrombus, a diamond indicates the location of the vein wall, and an arrow identifies areas of positive staining.

Figure 5. Immunohistochemistry of thrombi. A–C. IBA1 staining for macrophages D–F. LY6G staining for neutrophils. G–I. H&E staining for erythrocyte, platelet, and plasma protein/fibrin content. A star indicates the location of the thrombus, a diamond indicates the location of the vein wall, and an arrow identifies areas of positive staining.
Supplemental material

Supplementary Material

Download PDF (417.3 KB)

Data availability statement

Data generated for this study are available through request to the corresponding authors.